01 mayo 2012

JACC: CARDIOVASCULAR INTERVENTIONS. Predictive Factors, Efficacy, and Safety of Balloon Post-Dilation After Transcatheter Aortic Valve Implantation With a Balloon-Expandable Valve

Luis Nombela-Franco, MD; Josep Rodés-Cabau, MD; Robert DeLarochellière, MD; Eric Larose, MD; Daniel Doyle, MD; Jacques Villeneuve, MD; Sébastien Bergeron, MD; Mathieu Bernier, MD; Ignacio J. Amat-Santos, MD; Michael Mok, MD; Marina Urena, MD; Michel Rheault, MD; Jean Dumesnil, MD; Mélanie Côté, MSc; Philippe Pibarot, PhD; Eric Dumont, MD

Objectives: This study sought to evaluate the predictive factors, effects, and safety of balloon post-dilation (BPD) for the treatment of significant paravalvular aortic regurgitation (AR) after transcatheter aortic valve implantation (TAVI).

01 mayo 2013

JACC. Patterns of Use and Comparative Effectiveness of Bleeding Avoidance Strategies in Men and Women Following Percutaneous Coronary Interventions. An Observational Study From the National Cardiovascular Data Registry

Stacie L. Daugherty, MD, MSPH; Lauren E. Thompson, MD; Sunghee Kim, PhD; Sunil V. Rao, MD; Sumeet Subherwal, MD, MBA; Thomas T. Tsai, MD, MSc; John C. Messenger, MD; Frederick A. Masoudi, MD, MSPH

Objectives: This study sought to compared the use and effectiveness of bleeding avoidance strategies (BAS) by sex.

01 mayo 2012

JACC: CARDIOVASCULAR INTERVENTIONS. Structural Integrity of Balloon-Expandable Stents After Transcatheter Aortic Valve Replacement. Assessment by Multidetector Computed Tomography

Alexander B. Willson, MBBS, MPH; John G. Webb, MD; Ronen Gurvitch, MBBS; David A. Wood, MD; Stefan Toggweiler, MD; Ronald Binder, MD; Melanie Freeman, MBBS; Mark Madden, MD; Cameron Hague, MD; Jonathon Leipsic, MD

Objectives: This study sought to evaluate the structural integrity of balloon-expandable stents used in transcatheter aortic valve replacement.

01 mayo 2012

JACC: CARDIOVASCULAR INTERVENTIONS. Factors Predicting and Having an Impact on the Need for a Permanent Pacemaker After CoreValve Prosthesis Implantation Using the New Accutrak Delivery Catheter System

Antonio J. Muñoz-García, MD, PhD; José M. Hernández-García, MD, PhD; Manuel F. Jiménez-Navarro, MD, PhD; Juan H. Alonso-Briales, MD; Antonio J. Domínguez-Franco, MD; Julia Fernández-Pastor, MD; Jose Peña Hernández, MD; Alberto Barrera Cordero, MD; Javier Alzueta Rodríguez, MD, PhD; Eduardo de Teresa-Galván, MD, PhD

Objectives: The purpose of this study was to evaluate the need for a permanent pacemaker after transcatheter aortic valve implantation with the CoreValve prosthesis (Medtronic, Inc., Minneapolis, Minnesota) using the new Accutrak delivery system (Medtronic, Inc.).

01 mayo 2012

JACC: CARDIOVASCULAR INTERVENTIONS. Transcatheter Aortic Valve Implantation in Patients With Low-Flow, Low-Gradient Aortic Stenosis

Alexander Lauten, MD; Ralf Zahn, MD; Martin Horack, MD; Horst Sievert, MD; Axel Linke, MD; Markus Ferrari, MD; Axel Harnath, MD; Eberhard Grube, MD; Ulrich Gerckens, MD; Karl-Heinz Kuck, MD; Stefan Sack, MD; Jochen Senges, MD; Hans R. Figulla, MD

Objectives: The purpose of this study was to evaluate the efficacy and outcome of transcatheter aortic valve implantation (TAVI) in patients with low-flow, low-gradient aortic stenosis (LG-AS).

01 mayo 2013

JACC. Renoprotective Effect of Remote Ischemic Post-Conditioning by Intermittent Balloon Inflations in Patients Undergoing Percutaneous Coronary Intervention

Spyridon Deftereos, MD; Georgios Giannopoulos, MD; Vasileios Tzalamouras, MD; Konstantinos Raisakis, MD; Charalambos Kossyvakis, MD; Andreas Kaoukis, MD; Vasiliki Panagopoulou, MD; Sofia Karageorgiou; Dimitrios Avramides, MD; Konstantinos Toutouzas, MD; George Hahalis, MD; Vlassios Pyrgakis, MD; Antonis S. Manolis, MD; Dimitrios Alexopoulos, MD; Christodoulos Stefanadis, MD; Michael W. Cleman, MD

Objectives The aim of the present study was to assess the efficacy of remote ischemic post-conditioning (RIPC) by repeated intermittent balloon inflations in preventing acute kidney injury (AKI) in patients with a non–ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention (PCI).

01 mayo 2012

JACC: CARDIOVASCULAR INTERVENTIONS. Multicenter Evaluation of Edwards SAPIEN Positioning During Transcatheter Aortic Valve Implantation With Correlates for Device Movement During Final Deployment FREE

Danny Dvir, MD; Ifat Lavi, PhD; Hélène Eltchaninoff, MD; Dominique Himbert, MD; Yaron Almagor, MD; Fleur Descoutures, MD; Alec Vahanian, MD; Christophe Tron, MD; Alain Cribier, MD; Ran Kornowski, MD

Objectives: This study sought to evaluate the exact location of Edwards SAPIEN (Edwards Lifesciences, Irvine, California) devices in different stages of implantation and to quantify possible operator-independent device movement during final deployment.

09 abril 2013

CIRCULATION. Long-Term Survival and Repeat Coronary Revascularization in Dialysis Patients After Surgical and Percutaneous Coronary Revascularization With Drug-Eluting and Bare Metal Stents in the United States

Gautam R. Shroff, MBBS; Craig A. Solid, PhD; Charles A. Herzog, MD

Background—Few published data describe long-term survival of dialysis patients undergoing surgical versus percutaneous coronary revascularization in the era of drug-eluting stents (DES).

01 mayo 2012

JACC: CARDIOVASCULAR INTERVENTIONS. Pathology of Transcatheter Valve Therapy

Fabian Nietlispach, MD; John G. Webb, MD; Jian Ye, MD; Anson Cheung, MD; Samuel V. Lichtenstein, MD, PhD; Ronald G. Carere, MD; Ronen Gurvitch, MB, BS; Christopher R. Thompson, MD; Avi J. Ostry, MD; Lise Matzke, MSc; Michael F. Allard, MD

Objectives: This study sought to report on the pathology of transcatheter aortic valves explanted at early and late time points after transcatheter aortic valve implantation.

01 mayo 2012

JACC: CARDIOVASCULAR INTERVENTIONS. Transcatheter Valve-In-Valve Implantation for Failed Balloon-Expandable Transcatheter Aortic Valves

Stefan Toggweiler, MD; David A. Wood, MD; Josep Rodés-Cabau, MD; Samir Kapadia, MD; Alexander B. Willson, MBBS, MPH; Jian Ye, MD; Anson Cheung, MD; Jonathon Leipsic, MD; Ronald K. Binder, MD; Ronen Gurvitch, MBBS; Melanie Freeman, MBBS; Christopher R. Thompson, MD; Lars G. Svensson, MD; Eric Dumont, MD; E. Murat Tuzcu, MD; John G. Webb, MD

Objectives: This study sought to evaluate outcomes after implantation of a second transcatheter heart valve (THV-in-THV) for acute THV failure.

01 abril 2012

CIRCULATION. Changing Epidemiology of Abdominal Aortic Aneurysms in England and Wales

Edward Choke, MBBS, FRCS, PhD; Badri Vijaynagar, MBBS, MRCS; John Thompson, PhD; Akhtar Nasim, MBBS, FRCS, MD; Matthew J. Bown, MBChB, FRCS, MD; Robert D. Sayers, MBChB, FRCS, MD

Background—Recent studies from Australia, New Zealand, and Sweden have reported declines in abdominal aortic aneurysm (AAA) incidence, prevalence, and mortality. This finding may have important implications for screening programs. This study determined trends in AAA incidence and mortality in England and Wales.

01 mayo 2012

JACC: CARDIOVASCULAR INTERVENTIONS. Need for Permanent Pacemaker as a Complication of Transcatheter Aortic Valve Implantation and Surgical Aortic Valve Replacement in Elderly Patients With Severe Aortic Stenosis

Rodrigo Bagur, MD; Josep Rodés-Cabau, MD; Ronen Gurvitch, MBBS; Éric Dumont, MD; James L. Velianou, MD; Juan Manazzoni, MD; Stefan Toggweiler, MD; Anson Cheung, MD; Jian Ye, MD; Madhu K. Natarajan, MD; Kevin R. Bainey, MD; Robert DeLarochellière, MD; Daniel Doyle, MD; Philippe Pibarot, DVM, PhD; Pierre Voisine, MD; Mélanie Côté, MSc; François Philippon, MD; John G. Webb, MD

Objectives: The aim of this study was to compare the incidence and predictive factors of complete atrioventricular block (AVB) and permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation (TAVI) versus surgical aortic valve replacement (SAVR).

01 abril 2012

CIRCULATION. Incidence and Prognosis of Resistant Hypertension in Hypertensive Patients

Background—Despite a recent American Heart Association (AHA) consensus statement emphasizing the importance of resistant hypertension, the incidence and prognosis of this condition are largely unknown.

01 abril 2013

JACC: CARDIOVASCULAR INTERVENTIONS. A Systematic Review and Meta-Analysis on Primary Percutaneous Coronary Intervention of an Unprotected Left Main Coronary Artery Culprit Lesion in the Setting of Acute Myocardial Infarction

Marije M. Vis, MD; Marcel A. Beijk, MD, PhD; Maik J. Grundeken, MD; Jan Baan, MD, PhD; Karel T. Koch, MD, PhD; Joanna J. Wykrzykowska, MD, PhD; E. Karin Arkenbout, MD, PhD; Jan G.P. Tijssen, PhD; Robbert J. de Winter, MD, PhD; Jan J. Piek, MD, PhD; José P.S. Henriques, MD, PhD

Objectives: This study sought to evaluate 30-day all-cause mortality of patients treated with primary percutaneous coronary intervention (PCI) presenting with an acute myocardial infarction (AMI) due to an unprotected left main coronary artery (ULMCA) culprit lesion. In addition, an average estimated mortality rate was extrapolated from the available data.

01 abril 2012

CIRCULATION. Comparative Outcomes for Patients Who Do and Do Not Undergo Percutaneous Coronary Intervention for Stable Coronary Artery Disease in New York

Edward L. Hannan, PhD; Zaza Samadashvili, MD; Kimberly Cozzens, MA; Gary Walford, MD; Alice K. Jacobs, MD; David R. Holmes Jr, MD; Nicholas J. Stamato, MD; Jeffrey P. Gold, MD; Samin Sharma, MD; Ferdinand J. Venditti, MD; Tia Powell, MD; Spencer B. King III, MD

Background—Little is known about what treatments patients receive after being diagnosed with stable coronary artery disease or what the comparative outcomes are for routine medical treatment (RMT) versus percutaneous coronary intervention (PCI) with RMT for patients in a setting apart from randomized controlled trials.